Tag: BCP

Women on Contraceptive Pill Should Pay $1,500 a Year More Tax – Forbes

~ Pharmer

Women on Contraceptive Pill Should Pay $1,500 a Year More Tax – Forbes.

Forbes contributor Tim Worstall has proposed that women who use birth control pills should be taxed similarly to other individuals and entities which pollute the water.   This is based on the endocrine disruption effects attributed to hormones which make their way into the general water supply from the urine of pill users.

It’s all about saving the fish from the sex altering effects of steroid hormone metabolites.  The green thing do do is to clean up the water,  and stick contraceptive users with the tab.  The profit margins from pill production are not high enough to cover the clean up so  Mr. Worstall takes manufacturers off the hook.

Unmentioned in the top linked  article is the gender bending effects that the feminizing hormones might be having on male humans.…..  This might be the impetus for the urgency to clean the water.

Pfizer: Whoopsie Baby!

~ Pharmer

Pfizer Recalls Birth-Control Pills – WSJ.com.

Pfizer recalls Birth Control Pills: Lo/Ovral-28 and the generic Norgestrel and Ethinyl Estradiol tablets due to a packaging error. Over a million dose-packs are recalled, but the company states a belief that only 30 packs are affected. One user alerted the company on Oct 19, that her blister pack had a pink (inactive) pill where a white (active pill should have been. The recall was announced at the end of January.

The recall has the ambulance chasers drooling and people wondering how to blame their pregnancies on the drug manufacturer, regardless of the real reason for failure.

The FDA lists the lots numbers and products involved in the recall.

Crony Capitalism at the FDA – Comes Back To Bite

~ Pharmer

Medical News: FDA Yaz Panel Had Ties to Industry – in Washington-Watch, FDA General from MedPage Today.

Some of the panalists on the FDA advisory committee which endorsed the Yaz and Yazmin branded birth control pills, had ties to Bayer, the manufacturer of those pills.

The panelists of the Reproductive Drugs Advisory Committee and the Drug Safety and Risk Management Advisory committee  jointly voted 15 to 11  that the benefits of drosperinone-containing BCPs outweighed the risks.

Some  members reported their financial  ties to Bayer,  and the FDA thought that was just fine, and not a conflict of interest sufficient for their exclusion from the advisory groups.

Sidney Wolfe, MD, of Public Citizen comsumer advocacy group had opposed that class of birth control pills due to risk of thromboembolism.   His role on the advisory committee was reduced to non-voting status due to his ‘intellectual conflicts’.

Intellectual conflict = bad.  Financial conflict = good.

What goes around, comes around, and Bayer has to feed the lawyers now, after years of untoward post-marketing experience.

Was this an purposefully  constructed food chain?